Glecaprevir for PTSD symptoms in Veterans
Treatments studied
Part of Digestive system, Infections, Mental health clinical trials.
This Phase 2/3 study tests whether glecaprevir/pibrentasvir can reduce post-traumatic stress disorder (PTSD) symptoms. It may help Veterans whose PTSD is still affecting daily life, alongside any allowed standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 70 years old
- You weigh at least 45 kg (about 99 pounds)
- You have a PTSD diagnosis confirmed on the CAPS-5 test within 7 days of joining
- You are eligible for VA (Veterans Affairs) healthcare
- If you could become pregnant, you must use reliable birth control or abstain during the study
- You can read, understand, and sign the informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a counseling approach called Cognitive Processing Therapy (CPT) with added memory support tools. It may help reduce PTSD symptoms while also supporting day-to-day memory challenges common in PTSD.
This trial tests whether a drug called psilocybin, combined with therapy, can help treat PTSD. It is for Georgia military members and veterans who have had PTSD for at least 6 months.
This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.
This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.
This trial tests an experimental medicine, HB-1, as a potential treatment for PTSD. It is a 8-week study to see if the medicine is safe and if it reduces PTSD symptoms. You must have a stable medication routine and be willing to take the study pill daily.
This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.